Surrogate endpoints need complementary patient reported outcomes
Latest BMJ blogs,
Cancer’s gold standard trial endpoint, overall survival (OS), is being overtaken by the growing use of surrogate endpoints.
Cancer’s gold standard trial endpoint, overall survival (OS), is being overtaken by the growing use of surrogate endpoints.
On 20th May 2020 we mark International Clinical Trials Day, an opportunity to recognize the people who carry out clinical…